Skip to main content
YDES logo

YD Bio Limited

YDESNASDAQHealthcareBiotechnology

$5.92Today:- (-)1Y −66.45%

As of Oct 16, 2026 close

Market cap
$477.38M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$1.70$22.00
Volume (live)
-
Avg. volume (3M)
502.64K

YD Bio (YDES) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), YD Bio used $6.60M of cash in operating activities and spent $1.44M on capital expenditures. That left free cash flow of −$8.04M.

YD Bio Cash Flow Statement Analysis

Values in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for YD Bio Limited (YDES) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income-8.31-1.410.013.798.70-2.54
Depreciation & Amortization0.210.100.000.000.000.00
Deferred Income Tax0.000.030.000.000.000.00
Change in Working Capital-1.690.05-0.13-0.700.630.09
Change in Accounts Receivable-0.36-0.01-0.060.000.000.00
Change in Inventory-1.840.03-0.030.000.000.00
Change in Accounts Payable0.390.010.01-0.530.530.07
Change in Other Working Capital0.130.01-0.04-0.170.100.02
Other Operating Activities3.190.010.05-6.11-10.022.19
Net Cash from Operating Activities-6.60-1.22-0.06-3.02-0.69-0.25
Investing Activities
Capital Expenditures-1.44-2.910.000.000.000.00
Purchases of Investments0.000.01-0.53-1.40-1.15-116.73
Sales/Maturities of Investments0.000.010.000.000.000.00
Other Investing Activities0.00-2.840.53101.780.000.00
Net Cash from Investing Activities-1.44-2.900.00100.38-1.15-116.73
Financing Activities
Debt Repayment0.00-0.03-0.034.201.150.00
Common Stock Issued10.707.860.050.000.00117.67
Common Stock Repurchased0.000.000.00-101.550.000.00
Other Financing Activities0.17-0.710.090.000.000.00
Net Cash from Financing Activities10.877.110.11-97.341.15117.67
Summary
Effect of Forex Changes on Cash0.040.060.000.000.000.00
Net Change in Cash2.883.050.060.01-0.690.69
Cash at Beginning of Period3.130.090.030.010.690.00
Cash at End of Period6.013.130.090.010.010.69
Free Cash Flow-8.04-4.13-0.06-3.02-0.69-0.25
Supplemental Disclosures
Interest Paid-0.000.000.00--

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About YD Bio Cash Flow

What is YD Bio's free cash flow?

YD Bio had negative free cash flow of $8.04M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of −$6.60M minus $1.44M of capital expenditures.

How much does YD Bio spend on capital expenditures?

YD Bio spent $1.44M on capital expenditures in fiscal 2025, compared with $2.91M a year earlier.

Does YD Bio pay dividends or buy back shares?

YD Bio's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition